The appearance of troglitazone, a potent glucose-lowering agent, marked a significant chapter in the control of type 2 diabetes. However, its withdrawal from the market due to severe hepatotoxicity spurred broad https://alyssakgaj988118.blognody.com/49195832/troglityzone-and-related-thiazolidinediones-a-comparative-overview